Viewing nowAtorlan Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

MFDS item code 201307558 · Approved 2013.05.30 · Insurance code 650303010
Improvement of hyperlipidemia; prevention of cardiovascular diseases (e.g., myocardial infarction and stroke)
This medication helps prevent cardiovascular events such as myocardial infarction, stroke, vascular surgery, and angina in adult and pediatric patients with various risk factors for cardiovascular disease. In particular, it reduces the risk of cardiovascular complications in patients with type 2 diabetes or coronary heart disease who have multiple risk factors. Furthermore, it lowers total cholesterol and LDL-cholesterol levels in patients with hyperlipidemia and increases HDL-cholesterol, thereby improving blood lipids. It is used as an adjunctive treatment for various types of dyslipidemia that are not controlled by diet, and it is utilized to lower cholesterol levels in specific pediatric populations. Thus, it is effectively used in the treatment of cardiovascular diseases and dyslipidemia.
Patients taking or about to take atorvastatin should follow a standard cholesterol-lowering diet. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring greater reductions in LDL cholesterol may start at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of more than 45 % is required). This drug is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses of this drug should be individualized according to the patient's characteristics, taking into account treatment goals and response. Lipid levels should be analyzed 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or use it when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is necessary. ○ Elderly patients: Efficacy and safety in patients 70 years of age or older are similar to those in the general adult patient population.
Pediatric patients with heterozygous familial hypercholesterolemia (10 ~ 17 years): The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on administering doses of this drug higher than 20 mg in pediatric patients).
This medication can cause serious muscle problems, so if symptoms of muscle pain or weakness occur, you should stop taking it immediately and consult your doctor. Patients with liver function problems should not take this medication and should undergo regular liver function tests. Pregnant women, women who may become pregnant, and breastfeeding women should not use this medication. This medication is not to be administered to children under 10 years of age. Patients with a history of alcoholism or liver disease should be evaluated and monitored carefully before taking this medication. This medication may interact with other drugs, so be sure to inform your doctor or pharmacist about any medications you are currently taking. Particularly caution is required when used in conjunction with certain antibiotics, antifungals, antivirals, and immunosuppressants. While taking this medication, if unusual symptoms such as muscle pain, weakness, or fever occur, you should inform a healthcare provider immediately. Taking this medication with grapefruit juice may increase its blood concentration, so it is advisable to avoid grapefruit juice. Elderly patients or those with decreased kidney function are at greater risk of muscle-related side effects and should be especially careful while taking this medication. During the course of treatment, it is important to regularly monitor liver function and muscle condition through blood tests. This medication should be kept out of reach of children and stored securely in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air or moisture from entering and should be kept at room temperature between 1 to 30 degrees Celsius. Storing it this way will help maintain the effectiveness of the medication for a longer period.
White, round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Jinyang Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.